Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients.
D000328:Adult; D000368:Aged; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002396:Catechols / Q000008:administration & dosage; D055598:Chemical Phenomena; D002621:Chemistry; D003863:Depression / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000097:blood; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D010525:Peripheral Nerves / Q000201:enzymology*; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D010919:Placebos; D011422:Propionates / Q000008:administration & dosage
D002396:Catechols; D006834:Hydrazines; D010648:Phenylacetates; D010919:Placebos; D011422:Propionates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases